Core Viewpoint - The company plans to transfer the income rights of 9.79% of shares in Longli Biological to Shandong Jinzi for 4.3962 million yuan, while also entrusting the corresponding voting rights to Shandong Jinzi, constituting a related party transaction [2][3][10]. Summary by Sections Related Party Transaction Overview - Shandong Gaoxin Investment intends to transfer the income rights of its 9.79% stake in Longli Biological to Shandong Jinzi, a subsidiary of its controlling shareholder, Shandong Lixin Investment Holding Group [2][3]. - The transaction requires approval from the company's shareholders' meeting, with related shareholders abstaining from voting [3][12]. Related Party Introduction - Lixin Group holds 69.57% of the company's A shares, while Shandong Jinzi is a subsidiary of Lixin Group [2][3]. - As of March 31, 2025, Shandong Jinzi reported total assets of 1139.44 billion yuan and net assets of 70.186 billion yuan [4]. Transaction Target Overview - The target asset is the income rights of 58,722,408 shares in Longli Biological, which has been suspended from trading since May 2022 [4][5]. - The shares are free from any encumbrances or legal disputes [4]. Financial Information of the Transaction Target - Longli Biological reported total assets of 478.272 million yuan and a net asset deficit of 583.18739 million yuan as of December 31, 2024 [5]. - The company has faced consecutive years of audit reports with disclaimers since 2017, affecting the valuation of its equity [5]. Pricing of the Transaction - The transfer price of 4.3962 million yuan was determined based on pre-suspension prices and the company's restructuring plan, considering asset risks and liquidity [5][6]. Agreement Details - The transaction involves signing a "Share Income Rights Transfer Agreement" and a "Voting Rights Entrustment Agreement" between Shandong Gaoxin Investment and Shandong Jinzi [6][10]. - The income rights transferred include all cash income and property rights derived from the shares [7][8]. Impact of the Transaction on the Company - The transaction is expected to help reduce the company's non-performing asset ratio and aligns with its long-term development strategy [10][11]. - After the transaction, the company anticipates an increase in investment income of approximately 15.7831 million yuan [11]. Approval Process for the Transaction - The board of directors has approved the transaction, which will be submitted for shareholder approval, with related parties abstaining from voting [12][13].

Core Viewpoint - The report evaluates the market value of the entire equity of Shandong Lixin Huijin Holdings Co., Ltd. as part of the share transfer process by Lixin Venture Capital Group Co., Ltd. The assessment is based on the financial status as of December 31, 2024, and indicates a significant increase in value compared to the net asset value [7][12][17]. Group 1: Assessment Overview - The assessment was commissioned by Lixin Venture Capital Group Co., Ltd. to evaluate the market value of the equity in Shandong Lixin Huijin Holdings Co., Ltd. as of December 31, 2024 [7][10]. - The assessed net assets of Shandong Lixin Huijin Holdings Co., Ltd. amounted to 1,422.17 million RMB, with a market value of 2,018.55 million RMB, resulting in an increase of 596.38 million RMB and a growth rate of 41.93% [8][12][17]. - The evaluation method used was the asset-based approach, focusing on the actual conditions of the assets and liabilities [8][26]. Group 2: Financial Data - As of December 31, 2024, the total assets of Shandong Lixin Huijin Holdings Co., Ltd. were reported at 2,679.54 million RMB, with total liabilities of 1,257.37 million RMB [12][14]. - The company achieved an operating income of 13.69 million RMB and a net profit of 60.21 million RMB for the year 2024 [12][14]. - The equity structure remained unchanged as of the assessment date, with Lixin Venture Capital Group holding a 10.05807% stake valued at 203.03 million RMB [8][12].

Core Viewpoint - The company held its 34th board meeting, where several key resolutions were passed regarding equity transfers and board elections, indicating ongoing strategic adjustments and governance changes within the organization [1][2][3]. Group 1: Equity Transfers - The company approved the transfer of a 10.0581% stake in Shandong Luxin Huijin Holdings Co., Ltd. to Shandong Investment Co., Ltd. for a price of 202.03 million yuan, with profits from the transfer period going to the buyer [1]. - A full subsidiary, Shandong High-tech Venture Capital Co., Ltd., will transfer the rights to the profits from its 9.79% stake in Longli Bio-Technology Co., Ltd. for 4.3962 million yuan, while also delegating voting rights to Shandong Financial Asset Management Co., Ltd. [2][3]. Group 2: Board Elections - The company is preparing for a board re-election as the current board's term is nearing its end, with nominations for both non-independent and independent directors being proposed [3][4]. - The nominated candidates for the 12th board include Wang Xudong, Ge Xiaohong, Pan Liquan, Ma Guanghui, Liu Xin, and Hou Zhenkai for non-independent positions, and Hu Yuanmu, Zhang Zhiyong, and Liu Hongwei for independent positions [4][5][6][7][8][9]. Group 3: Upcoming Shareholder Meeting - A temporary shareholder meeting is scheduled for June 30, 2025, to review the approved equity transfer proposals and the board election resolutions [5].

Group 1 - The company, Luxin Venture Capital Group Co., Ltd., is convening its first extraordinary general meeting of shareholders for 2025 on June 30, 2025 [1][3] - The meeting will utilize the Shanghai Stock Exchange's online voting system, with voting available from 9:15 AM to 3:00 PM on the day of the meeting [1][3] - The meeting will be held at 2:30 PM at the conference room located at 2788 A Tower, Aoti West Road, Jinan, Shandong Province [3][5] Group 2 - The agenda includes non-cumulative voting proposals and related party transactions, which have been approved by the company's board of directors [2][3] - Shareholders must register to attend the meeting, with registration available from June 24, 2025, and can be done in person or via electronic means [5][6] - Shareholders holding multiple accounts can aggregate their voting rights across all accounts for the meeting [4][8] Group 3 - The company has specified that shareholders must complete identity verification to vote via the internet platform [2][4] - The voting process allows shareholders to express their opinions on all proposals before submission [4][8] - The company has provided detailed instructions for proxy voting and the necessary documentation required for attendance [5][6]

山东省鲁信惠金控股有限公司 审计报告 上会师报字(2025)第 4210 号 上会会计师事务所(特殊普通合伙) 中国 上海 您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台（http://acc.mof.gov.cn）"进行在 D D D D D D D 0 D D 会会计师事务所(特殊普通合伙) nahai Certified Public Accountants (Special General Partne 审计报告 上会师报字(2025)第 4210 号 山东省鲁信惠金控股有限公司: 一、审计意见 我们审计了山东省鲁信惠金控股有限公司(以下简称"贵公司")财务报表, 包括 2024 年 12 月 31 日的合并及母公司资产负债表, 2024 年度的合并及母公司利润 表、合并及母公司现金流量表、合并及母公司所有者权益变动表以及相关财务报表 附注。 我们认为,后附的财务报表在所有重大方面按照企业会计准则的规定编制，公 允反映了贵公司 2024 年 12 月 31 日的合并及母公司财务状况以及 2024 年度的合并及 母公司经营成果和现金流量。 二、形成审计意见的基础 我们按照中国注册会计师审计准则 ...

本报告依据资产评估准则编制 鲁信创业投资集团股份有限公司拟转股 权所涉及山东省鲁信惠金控股有限公司 股东全部权益价值项目 资 产 评 估 报 告 中联鲁评报字【2025】第 13178 号 | 报告编码: | 3737080071202500198 | | --- | --- | | 合同编号: | 20250137A | | 报告类型: | 法定评估业务资产评估报告 | | 报告文号: | 中联鲁评报字【2025】第13178号 | | 报告名称: | 鲁信创业投资集团股份有限公司拟转股权所涉及山东省鲁信惠金 控股有限公司股东全部权益价值项目资产评估报告 | | 评估结论: | 2,018,552,306.21元 | | 评估报告日: | 2025年05月30日 | | 评估机构名称: | 中联资产评估集团山东有限公司 | | 签名人员: | 郭海果 (资产评估师) 正式会员 编号:37190194 | | | 王莹 (资产评估师) 见习会员 编号: 37230384 | 中联资产评估集团山东有限公司 二〇二五年五月三十日 一、本资产评估报告依据财政部发布的资产评估基本准则和中国 资产评估协会发布的资产评估 ...

| 证券代码：600783 | 股票简称：鲁信创投 | | | 编号：临 | 2025-19 | | --- | --- | --- | --- | --- | --- | | 债券代码：155271 | 债券简称：19 | 鲁创 | 01 | | | | 债券代码：163115 | 债券简称：20 | 鲁创 | 01 | | | | 债券代码：137784 | 债券简称：22 | 鲁创 | K1 | | | | 债券代码：240884 | 债券简称：24 | 鲁创 | K1 | | | 鲁信创业投资集团股份有限公司 者关注本次交易的进展公告，注意投资风险。 一、关联交易概述 为进一步压降不良资产率，山东高新投拟将其持有的龙力生物 9.79%股份对 应的收益权以 439.62 万元的价格转让给山东金资，同时将相应股份对应的表决 权委托给山东金资行使。 截至本次关联交易为止，过去 12 个月内公司与同一关联人之间发生的关联 交易达到 3,000 万元以上，且达到公司最近一期经审计净资产绝对值 5%以上。 根据相关规定，本次关联交易事项需提交公司股东会审议，关联股东应回避表决。 二、关联人介绍 （一）关联关系介绍 ...

| 证券代码：600783 | 股票简称：鲁信创投 | | | 编号：临 | 2025-18 | | --- | --- | --- | --- | --- | --- | | 债券代码：155271 | 债券简称：19 | 鲁创 | 01 | | | | 债券代码：163115 | 债券简称：20 | 鲁创 | 01 | | | | 债券代码：137784 | 债券简称：22 | 鲁创 | K1 | | | | 债券代码：240884 | 债券简称：24 | 鲁创 | K1 | | | 鲁信创业投资集团股份有限公司 关于公司转让山东省鲁信惠金控股有限公司股权 暨关联交易的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 1 鲁信创业投资集团股份有限公司（以下简称"鲁信创投"或"公司"） 拟采用非公开协议转让的方式，将持有的山东省鲁信惠金控股有限公司 （以下简称"鲁信惠金"）全部 10.0581%股权以 20,302.74 万元的价格 转让给山东省投资有限公司（以下简称"山东投资"），评估基准日至 产权交割 ...

证券代码：600783 证券简称：鲁信创投 公告编号：2025-20 鲁信创业投资集团股份有限公司 关于召开2025年第一次临时股东会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、 召开会议的基本情况 (一) 股东会类型和届次 2025年第一次临时股东会 召开的日期时间：2025 年 6 月 30 日 14 点 30 分 召开地点：山东省济南市奥体西路 2788 号 A 塔 2720 会议室 (五) 网络投票的系统、起止日期和投票时间 股东会召开日期：2025年6月30日 本次股东会采用的网络投票系统：上海证券交易所股东会网络投票系统 (二) 股东会召集人：董事会 (三) 投票方式：本次股东会所采用的表决方式是现场投票和网络投票相结合 的方式 (四) 现场会议召开的日期、时间和地点 网络投票系统：上海证券交易所股东会网络投票系统 网络投票起止时间：自2025 年 6 月 30 日 至2025 年 6 月 30 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 东会召开当日的交 ...

| 证券代码：600783 | 股票简称：鲁信创投 | | | 2025-17 | 编号：临 | | --- | --- | --- | --- | --- | --- | | 债券代码：155271 | 债券简称：19 | 鲁创 | 01 | | | | 债券代码：163115 | 债券简称：20 | 鲁创 | 01 | | | | 债券代码：137784 | 债券简称：22 | 鲁创 | K1 | | | | 债券代码：240884 | 债券简称：24 | 鲁创 | K1 | | | 鲁信创业投资集团股份有限公司 十一届三十四次董事会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 鲁信创业投资集团股份有限公司（以下简称"公司"）第十一届董事会第三 十四次会议于 2025 年 6 月 12 日以现场方式召开，本次会议通知已于 2025 年 6 月 10 日以书面方式发出。会议应出席董事 9 人，实际出席董事 9 人。会议符合 《公司法》和《公司章程》的有关规定。会议审议并通过了以下议案： 一、审议通过了《关于公司转 ...